Sharps Technology, Inc. (STSS)
USD 4.75
(-9.35%)
USD 4.75
(-9.35%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 1.7 Million USD | 819.86% |
| 2022 | 185.8 Thousand USD | 52.31% |
| 2021 | 121.99 Thousand USD | 0.0% |
| 2020 | - USD | 0.0% |
| 2019 | - USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 1.84 Million USD | 7.8% |
| 2024 Q2 | 1.88 Million USD | 2.36% |
| 2023 Q4 | 1.7 Million USD | 32.78% |
| 2023 Q2 | 992.54 Thousand USD | 81.55% |
| 2023 FY | 1.7 Million USD | 819.86% |
| 2023 Q1 | 546.72 Thousand USD | 194.25% |
| 2023 Q3 | 1.28 Million USD | 29.68% |
| 2022 Q3 | 233.74 Thousand USD | 83.41% |
| 2022 FY | 185.8 Thousand USD | 52.31% |
| 2022 Q2 | 127.44 Thousand USD | 4.46% |
| 2022 Q1 | 121.99 Thousand USD | 0.0% |
| 2022 Q4 | 185.8 Thousand USD | -20.51% |
| 2021 Q1 | - USD | 0.0% |
| 2021 Q3 | 117.98 Thousand USD | 0.0% |
| 2021 Q4 | 121.99 Thousand USD | 3.39% |
| 2021 FY | 121.99 Thousand USD | 0.0% |
| 2021 Q2 | - USD | 0.0% |
| 2020 Q4 | - USD | 0.0% |
| 2020 FY | - USD | 0.0% |
| 2019 FY | - USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 17.87 Million USD | 90.439% |
| AngioDynamics, Inc. | 60.61 Million USD | 97.18% |
| AtriCure, Inc. | 67.89 Million USD | 97.483% |
| Avinger, Inc. | 5.29 Million USD | 67.74% |
| Azenta, Inc. | 128.19 Million USD | 98.667% |
| BioLife Solutions, Inc. | 43.45 Million USD | 96.067% |
| The Cooper Companies, Inc. | 735.6 Million USD | 99.768% |
| Daxor Corporation | - USD | -Infinity% |
| Ekso Bionics Holdings, Inc. | 5.05 Million USD | 66.156% |
| Femasys Inc. | 667.11 Thousand USD | -156.197% |
| GlucoTrack, Inc. | - USD | -Infinity% |
| Harvard Bioscience, Inc. | 24.71 Million USD | 93.085% |
| Hologic, Inc. | 679.8 Million USD | 99.749% |
| ICU Medical, Inc. | 709.36 Million USD | 99.759% |
| Intuitive Surgical, Inc. | 1.22 Billion USD | 99.86% |
| KORU Medical Systems, Inc. | 3.48 Million USD | 50.905% |
| LeMaitre Vascular, Inc. | 52.33 Million USD | 96.734% |
| Innovative Eyewear, Inc. | 856.75 Thousand USD | -99.488% |
| Innovative Eyewear, Inc. | 856.75 Thousand USD | -99.488% |
| Masimo Corporation | 545 Million USD | 99.686% |
| Microbot Medical Inc. | - USD | -Infinity% |
| Meihua International Medical Technologies Co., Ltd. | 1.61 Million USD | -5.683% |
| Merit Medical Systems, Inc. | 303.87 Million USD | 99.438% |
| Nephros, Inc. | 2.47 Million USD | 30.804% |
| NovoCure Limited | 38.15 Million USD | 95.52% |
| NEXGEL, Inc. | 1.31 Million USD | -29.578% |
| NEXGEL, Inc. | 1.31 Million USD | -29.578% |
| Singular Genomics Systems, Inc. | 13.57 Million USD | 87.407% |
| OraSure Technologies, Inc. | 47.61 Million USD | 96.41% |
| Pro-Dex, Inc. | 15.26 Million USD | 88.807% |
| Pulse Biosciences, Inc. | - USD | -Infinity% |
| Predictive Oncology Inc. | 494.37 Thousand USD | -245.717% |
| Precision Optics Corporation, Inc. | 2.86 Million USD | 40.409% |
| QuidelOrtho Corporation | 577.8 Million USD | 99.704% |
| Repligen Corporation | 202.32 Million USD | 99.155% |
| Sanara MedTech Inc. | 4.71 Million USD | 63.771% |
| STAAR Surgical Company | 35.13 Million USD | 95.135% |
| Utah Medical Products, Inc. | 9.58 Million USD | 82.163% |
| DENTSPLY SIRONA Inc. | 624 Million USD | 99.726% |
| Jin Medical International Ltd. | 5.05 Million USD | 66.177% |